Cargando…

Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction

• Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF.

Detalles Bibliográficos
Autores principales: Pierce, Janet D., Shen, Qiuhua, Vacek, James, Rahman, Faith K., Krueger, Kathryn J., Gupta, Bhanu, Hiebert, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251495/
https://www.ncbi.nlm.nih.gov/pubmed/32477499
http://dx.doi.org/10.1016/j.amsu.2020.05.009
_version_ 1783538977994702848
author Pierce, Janet D.
Shen, Qiuhua
Vacek, James
Rahman, Faith K.
Krueger, Kathryn J.
Gupta, Bhanu
Hiebert, John B.
author_facet Pierce, Janet D.
Shen, Qiuhua
Vacek, James
Rahman, Faith K.
Krueger, Kathryn J.
Gupta, Bhanu
Hiebert, John B.
author_sort Pierce, Janet D.
collection PubMed
description • Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF.
format Online
Article
Text
id pubmed-7251495
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72514952020-05-29 Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction Pierce, Janet D. Shen, Qiuhua Vacek, James Rahman, Faith K. Krueger, Kathryn J. Gupta, Bhanu Hiebert, John B. Ann Med Surg (Lond) Review Article • Manuscript Highlights. • HFpEF is associated with reduced ATP production in the myocardium. • Ubiquinol and d-ribose both contribute to the generation of myocardial ATP. • Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF. Elsevier 2020-05-18 /pmc/articles/PMC7251495/ /pubmed/32477499 http://dx.doi.org/10.1016/j.amsu.2020.05.009 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Pierce, Janet D.
Shen, Qiuhua
Vacek, James
Rahman, Faith K.
Krueger, Kathryn J.
Gupta, Bhanu
Hiebert, John B.
Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
title Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
title_full Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
title_fullStr Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
title_full_unstemmed Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
title_short Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
title_sort potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251495/
https://www.ncbi.nlm.nih.gov/pubmed/32477499
http://dx.doi.org/10.1016/j.amsu.2020.05.009
work_keys_str_mv AT piercejanetd potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction
AT shenqiuhua potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction
AT vacekjames potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction
AT rahmanfaithk potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction
AT kruegerkathrynj potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction
AT guptabhanu potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction
AT hiebertjohnb potentialuseofubiquinolanddriboseinpatientswithheartfailurewithpreservedejectionfraction